Diversified Healthcare Trust Announces Annual Meeting Results
Diversified Healthcare Trust (Nasdaq: DHC) announced the results of its 2021 Annual Meeting of Shareholders. Key outcomes include the appointment of Jennifer F. Francis as President and CEO, following her role as President and COO since 2018. Lisa Harris Jones was elected as an Independent Trustee with 71.1% of votes, while Francis received 87.1% as Managing Trustee. Shareholder approval for executive compensation was 89.9%, and Deloitte & Touche LLP was ratified as independent auditors with 99.3% support. DHC’s portfolio comprises 396 properties across 36 states, valued at $8.2 billion.
- Jennifer F. Francis appointed as President and CEO, indicating leadership stability.
- High shareholder support for governance changes: 71.1% for Lisa Harris Jones and 87.1% for Jennifer F. Francis.
- Strong approval of executive compensation at 89.9%, reflecting shareholder confidence.
- Deloitte & Touche LLP ratified as independent auditors with overwhelming 99.3% approval, ensuring financial oversight.
- None.
Diversified Healthcare Trust (Nasdaq: DHC) today announced the results of its 2021 Annual Meeting of Shareholders which was held yesterday. Additionally, the company has appointed Jennifer F. Francis as President and Chief Executive Officer, effective immediately. Ms. Francis has served as President and Chief Operating Officer since 2018. The results of the Annual Meeting of Shareholders were as follows.
Lisa Harris Jones was elected as an Independent Trustee. The final tabulation of the percentage of shareholders’ votes cast for this Independent Trustee is as follows:
Independent Trustee |
|
Percentage of Shares Voted For |
Lisa Harris Jones |
|
|
|
|
Jennifer F. Francis was elected as a Managing Trustee. The final tabulation of the percentage of shareholders’ votes cast for this Managing Trustee is as follows:
Managing Trustee |
Percentage of Shares Voted For |
|
Jennifer F. Francis |
|
Shareholders voted to approve executive compensation by means of an advisory vote:
Proposal |
Percentage of Shares Voted For |
|
Approval of executive compensation |
|
Shareholders ratified the appointment of Deloitte & Touche LLP as DHC’s independent auditors to serve for the 2021 fiscal year:
Proposal |
Percentage of Shares Voted For |
|
Ratification of Independent Auditors |
|
About Diversified Healthcare Trust
Diversified Healthcare Trust (Nasdaq: DHC) is a real estate investment trust (REIT) focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum: by care delivery and practice type, by scientific research disciplines, and by property type and location. As of March 31, 2021, DHC’s
A Maryland Real Estate Investment Trust with transferable shares of beneficial interest listed on the Nasdaq.
No shareholder, Trustee or officer is personally liable for any act or obligation of the Trust.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210604005098/en/
FAQ
What were the results of Diversified Healthcare Trust's 2021 Annual Meeting of Shareholders?
Who was elected as an Independent Trustee for DHC?
What percentage of shareholders approved executive compensation at DHC?
Who was ratified as the independent auditor for DHC for the fiscal year?